Skip to main content
SpringerLink
Log in

Perinatal Problems of Thrombosis and Haemostasis

  • Conference paper
Perinatal Thrombosis and Hemostasis

  • 69 Accesses

Abstract

Prevention and treatment of deep vein thrombosis during pregnancy presents special problems. The benefit of treatment for the original condition must be weighed against the subsequent risk of placental or fetal haemorrhage. Owing to the high risk of recurrence, prophylactic treatment is required throughout pregnancy, during delivery, and in the puerperium. At an early stage of pregnancy, the risk ot teratogenetic effects needs also to be taken into consideration.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Åstedt B, Robertson B, Haeger K (1974) Experience with standardized streptokinase therapy of deep venous thrombosis. Surg Gynecol Obstet 139: 387–388

    PubMed  Google Scholar 

  2. Flessa HC, Kapstrom AB, Glueck HI, Will JJ (1965) Placental transport of heparin. Am J Obstet Gynecol 93: 570–573

    PubMed  CAS  Google Scholar 

  3. Forestier F, Daffos F, Capella-Pavlovsky M (1984) Low molecular weight heparin (PK 10169) does not cross the placenta during the second trimester of pregnancy: study by direct fetal blood sampling under ultrasound. Thromb Res 34: 557

    Article  PubMed  CAS  Google Scholar 

  4. Forestier F, Daffos F, Rainaut M, Toulemonde F (1987) Low molecular weight Heparin (CY 216) does not cross the placenta during the third trimester of pregnancy. Thromb Hemost 57: 234

    CAS  Google Scholar 

  5. Âstedt B, Isacson S, Nilsson IM, Pandolfi M (1970) Fibrinolytic activity of veins during pregnancy. Acta Obstet Gynecol Scand 48: 171–173

    Article  Google Scholar 

  6. Bonnar J, McNicol GP, Douglas AS (1970) Coagulation and fibrinolytic mechanisms during and after childbirth. Br Med J 2: 200–203

    Article  PubMed  CAS  Google Scholar 

  7. Bloomfield DK (1970) Fetal deaths and malformations associated with the use of coumarin derivatives in pregnancy. Am J Obstet Gynecol 107: 883–888

    PubMed  CAS  Google Scholar 

  8. Carson M, Reid M (1976) Warfarin and fetal abnormality. Lancet 1: 1127

    Article  Google Scholar 

  9. Hall GJ (1967) Warfarin and fetal abnormality. Lancet 1: 1127

    Google Scholar 

  10. Holtzgreve W, Carey JC, Hall BD (1976) Warfain-induced fetal abnormalities. Lancet 2: 914–915

    Article  Google Scholar 

  11. DiSaia PJ (1966) Pregnancy and delivery of a patient with a Starr-Edwards mitral valve prosthesis. Obstet Gynecol 28: 469–472

    Google Scholar 

  12. Kerber IJ, Warr OS, Richardson C (1968) Pregnancy in a patient with a prosthetic mitral valve. JAMA 203: 157–159

    Article  Google Scholar 

  13. Tejani N (1973) Anticoagulant therapy with cardiac valve prosthesis during pregnancy. Obstet Gynecol 42: 785–793

    PubMed  CAS  Google Scholar 

  14. Becker MH, Genieser NB, Finegold M, Miranda D, Spackman T (1975) Chondrodysplasia punctata. Am J Dis Child 129: 356–359

    PubMed  CAS  Google Scholar 

  15. Fourie DT, Hay IT (1975) Warfarin as a possible teratogen. S Afr Med J 49: 2081–2083

    PubMed  CAS  Google Scholar 

  16. Pettifor JM, Benson R (1975) Congenital malformations associated with the administration of oral anticoagulants during pregnancy. J Pediatr 86: 459–462

    Article  PubMed  CAS  Google Scholar 

  17. Shaul WL, Emery H, Hall GJ (1975) Chondrodysplasia punctata and maternal warfarin use during pregnancy. Am J Dis Child 129: 360–362

    PubMed  CAS  Google Scholar 

  18. Sherman S, Hall BD (1976) Warfarin and fetal abnormality. Lancet 1: 692

    Article  PubMed  CAS  Google Scholar 

  19. Quenneville G, Barton B, McDevitt E, Wright IS (1959) The use of anticoagulants for thrombophlebitis during pregnancy. Am J Obstet Gynecol 77: 1135–1149

    PubMed  CAS  Google Scholar 

  20. Warkany J (1975) A warfarin embryopathy? Am J Dis Child 129: 287–288

    PubMed  CAS  Google Scholar 

  21. von Syndow G (1947) Hypoprothrombinemia and cerebral injury in infant after dicumarol treatment of mother. Nord Med 34: 1171–1172

    Google Scholar 

  22. Sach JJ, Labate JS (1949) Dicumarol in the treatment of antenatal thrombo-embolic disease: Report of a case with hemorrhagic manifestations in the fetus. Am J Obstet Gynecol 57: 965–971

    Google Scholar 

  23. Gordon RR, Dean T (1955) Fetal deaths from antenatal anticoagulant therapy. Br Med J 2: 719–721

    Article  PubMed  CAS  Google Scholar 

  24. VillaSanta U (1965) Thromboembolic disease in pregnancy. Am J Obstet Gynecol 93; 142

    PubMed  CAS  Google Scholar 

  25. Iturbe-Alessio I, del Carmen Fonseca M, Mutchinik O, Santos MA, Zajarias A, Salazar E (1986) Risks of anticoagulant therapy in pregnant women with artificial heart valves. N Engl J Med 315: 1390–1393

    Article  PubMed  CAS  Google Scholar 

  26. Kakkar W (1975) Deep vein thrombosis. Detection and prevention. Circulation 51: 8–19

    Article  PubMed  CAS  Google Scholar 

  27. Crawford JS (1978) Principles and practice of obstetrics anesthesia, 4th edn. Black-well Scientific Publications, Oxford, pp 182–183

    Google Scholar 

  28. Orme MLE, Lewis PJ, de Swiet M, Serlin MJ, Sibeon R, Baty JD, Breckenridge AM (1977) May mothers given warfarin breast-feed their infants? Br Med J 1: 1564–1565

    Article  PubMed  CAS  Google Scholar 

  29. Hellgren M, Tenbgorn L, Abildgaard U (1982) Pregnancy in women with congenital antithrombin III deficiency: experience of treatment with heparin and antithrombin. Gynecol Obstet Invest 14: 127–141

    Article  PubMed  CAS  Google Scholar 

  30. Hellgren M, Nygårds EB, Robbe H (1982) Antithrombin III in late pregnancy. Acta Obstet Gynecol Scand 61: 187–189

    Article  PubMed  CAS  Google Scholar 

  31. Griffith GC, Nichols G, Asher JD, Hanagan B (1965) Heparin osteoporosis. JAMA 193: 91–94

    Article  PubMed  CAS  Google Scholar 

  32. Wise PH, Hall AJ (1980) Heparin-induced osteopenia in pregnancy. Br Med J 281: 110–111

    Article  PubMed  CAS  Google Scholar 

  33. Cines DB, Kaywin P, Bina M, Tomaski A, Schreiber AD (1980) Heparin-associated thrombocytopenia. N Engl J Med 303: 788–795

    Article  PubMed  CAS  Google Scholar 

  34. Chong BH, Pitney WR, Castaldi PA (1982) Heparin-induced thrombocytopenia: an association of thrombotic complications with heparin-dependent IgG antibody that induces thromboxane synthesis and platelet aggregation. Lancet 2: 1246–1248

    Article  PubMed  CAS  Google Scholar 

  35. Babcock RB, Wesley Dumper C, Scharfman WB (1976) Heparin-induced immune thrombocytopenia. N Engl J Med 295: 237–241

    Article  PubMed  CAS  Google Scholar 

  36. de Swiet M, Bulpitt CJ, Lewis PJ (1980) How obstetricians use anticoagulants in the prophylaxis of thromboembolism. J Obstet Gynecol 1: 29–32

    Article  Google Scholar 

  37. Åstedt B (1988) Hemorrhagic diathesis due to pathological proteolysis. In: Renck H (ed) Bleeding and thrombotic disorders in the surgical patient. Appleton & Lange, Norwalk, pp 53–59

    Google Scholar 

  38. Svanberg L, Åstedt B, Nilsson IM (1980) Abruptio placenta—treatment with the fibrinolytic inhibitor tranexamic acid. Acta Obstet Gynecol Scand 59: 127–30

    Article  PubMed  CAS  Google Scholar 

  39. Åstedt B, Nilsson IM (1978) Recurrent abruptio placentae treated with the fibrinolytic inhibitor tranexamic acid. Br Med J 1: 756–7

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Obstetrics and Gynecology, University Hospital, S-221 85, Lund, Sweden

    Birger Åstedt

Authors
  1. Birger Åstedt
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. College of Medical Technology, Hokkaido University, Kita-ku, Sapporo 060, Japan

    Shigenori Suzuki M.D.

  2. University of Colorado School of Medicine, Denver, CO, 80262, USA

    William E. Hathaway M.D.

  3. Trinity College, Department of Obstetrics and Gynaecology, St. James’s Hospital, University of Dublin, Dublin, Ireland

    John Bonnar M.D., FRCOG

  4. Universitäts-Kinderklinik, 7800, Freiburg, Federal Republic of Germany

    Anton H. Sutor M.D.

Rights and permissions

Reprints and permissions

Copyright information

© 1991 Springer Japan

About this paper

Cite this paper

Åstedt, B. (1991). Perinatal Problems of Thrombosis and Haemostasis. In: Suzuki, S., Hathaway, W.E., Bonnar, J., Sutor, A.H. (eds) Perinatal Thrombosis and Hemostasis. Springer, Tokyo. https://doi.org/10.1007/978-4-431-65871-9_11

Download citation

  • DOI: https://doi.org/10.1007/978-4-431-65871-9_11

  • Publisher Name: Springer, Tokyo

  • Print ISBN: 978-4-431-65873-3

  • Online ISBN: 978-4-431-65871-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation